This inventor holds 1 USPTO granted patent. Top assignee: Lupin, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Suryabhan Prabhakar Dange: Innovator in Pharmaceutical Processes
Introduction
Suryabhan Prabhakar Dange is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug formulation. His work exemplifies the intersection of science and technology in improving healthcare solutions.
Latest Patents
Dange holds a patent for a process for the preparation of the polymorphic form of Mirabegron. This invention is directed towards the preparation of α-form crystal of Mirabegron, a compound known for its therapeutic applications. The patent highlights his expertise in crystallization processes, which are crucial for the efficacy and stability of pharmaceutical products. He has 1 patent to his name.
Career Highlights
Suryabhan Prabhakar Dange is currently associated with Lupin, Inc., a leading global pharmaceutical company. His role involves research and development, where he focuses on innovative drug formulations. His contributions have been instrumental in advancing the company's product offerings and enhancing patient care.
Collaborations
Dange has collaborated with several professionals in his field, including notable coworkers such as Girij Pal Singh and Dhananjai Shrivastava. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical processes.
Conclusion
Suryabhan Prabhakar Dange's work in the pharmaceutical industry showcases his commitment to innovation and excellence. His patent for the preparation of Mirabegron reflects his significant contributions to drug development. Through his career at Lupin, Inc., he continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
